ArticleFrontiers in cardiovascular medicine2022

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology.

Anzhu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.